42 related articles for article (PubMed ID: 18161868)
1. Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Sullivan LJ; Koewler NJ; Bauss F; Mantyh PW
J Pain Symptom Manage; 2008 Sep; 36(3):289-303. PubMed ID: 18411018
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma.
Nham TT; Guiho R; Brion R; Amiaud J; Le Royer BB; Gomez-Brouchet A; Rédini F; Bertin H
Oral Dis; 2024 Feb; ():. PubMed ID: 38376129
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.
Quattrocchi CC; Dell'Aia P; Errante Y; Occhicone F; Longo D; Virzì V; Tonini G; Napoli N; Santini D; Beomonte Zobel B
J Bone Oncol; 2012 Jun; 1(1):24-9. PubMed ID: 26909251
[TBL] [Abstract][Full Text] [Related]
4. Relative Effects of Radiation-Induced Changes in Bone Mass, Structure, and Tissue Material on Vertebral Strength in a Rat Model.
Emerzian SR; Wu T; Vaidya R; Tang SY; Abergel RJ; Keaveny TM
J Bone Miner Res; 2023 Jul; 38(7):1032-1042. PubMed ID: 37191221
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients.
Rühle A; Nya Yompang VA; Spohn SKB; Stoian R; Zamboglou C; Gkika E; Grosu AL; Nicolay NH; Sprave T
Radiat Oncol; 2022 Sep; 17(1):153. PubMed ID: 36071522
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial changes in bone mineral content and mechanical properties during breast-cancer bone metastases.
Verbruggen ASK; McCarthy EC; Dwyer RM; McNamara LM
Bone Rep; 2022 Dec; 17():101597. PubMed ID: 35754558
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).
Ringdahl-Mayland B; Thamm DH; Martin TW
Front Vet Sci; 2022; 9():892297. PubMed ID: 35619604
[TBL] [Abstract][Full Text] [Related]
8. Relations Between Bone Quantity, Microarchitecture, and Collagen Cross-links on Mechanics Following In Vivo Irradiation in Mice.
Pendleton MM; Emerzian SR; Sadoughi S; Li A; Liu JW; Tang SY; O'Connell GD; Sibonga JD; Alwood JS; Keaveny TM
JBMR Plus; 2021 Nov; 5(11):e10545. PubMed ID: 34761148
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy combined with bone-modifying agents ameliorates local control of osteolytic bone metastases in breast cancer.
Tanaka H; Makita C; Manabe Y; Kajima M; Matsuyama K; Matsuo M
J Radiat Res; 2020 May; 61(3):494-498. PubMed ID: 32266394
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue.
Costa S; Reagan MR
Front Endocrinol (Lausanne); 2019; 10():587. PubMed ID: 31555210
[TBL] [Abstract][Full Text] [Related]
11. Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer.
Wang Q; Sun B; Meng X; Liu C; Cong Y; Wu S
J Radiat Res; 2019 May; 60(3):394-400. PubMed ID: 30785994
[TBL] [Abstract][Full Text] [Related]
12. Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes.
Lin Z; Liu Y; Ma X; Hu S; Zhang J; Wu Q; Ye W; Zhu S; Yang D; Qu D; Jiang J
Sci Rep; 2015 Jun; 5():11709. PubMed ID: 26122018
[TBL] [Abstract][Full Text] [Related]
13. Long-term loss of osteoclasts and unopposed cortical mineral apposition following limited field irradiation.
Oest ME; Franken V; Kuchera T; Strauss J; Damron TA
J Orthop Res; 2015 Mar; 33(3):334-42. PubMed ID: 25408493
[TBL] [Abstract][Full Text] [Related]
14. The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.
Hadji P; Coleman R; Gnant M; Green J
Ann Oncol; 2012 Nov; 23(11):2782-2790. PubMed ID: 22730099
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study.
Atahan L; Yildiz F; Cengiz M; Kaplan B; Ozkan M; Yazici G; Gündoğ M; Haydaroğlu A; Korcum AF; Sengöz M; Dinçer M; Akmansu M; Engin K; Hayran M
Support Care Cancer; 2010 Jun; 18(6):691-8. PubMed ID: 19484483
[TBL] [Abstract][Full Text] [Related]
16. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
Arrington SA; Damron TA; Mann KA; Allen MJ
J Surg Oncol; 2008 Mar; 97(3):284-90. PubMed ID: 18161868
[TBL] [Abstract][Full Text] [Related]
17. Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
Arrington SA; Fisher ER; Willick GE; Mann KA; Allen MJ
Calcif Tissue Int; 2010 Sep; 87(3):263-72. PubMed ID: 20563797
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
19. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
